Search
Menu
Gentec Electro-Optics Inc   - Measure With Gentec Accuracy LB

The National Cancer Institute

Facebook X LinkedIn Email
The National Cancer Institute has awarded a three-year, $1.9 million grant to Lucid Inc. of Rochester, N.Y., to evaluate the company’s VivaScope in vivo confocal microscopy technology for the diagnosis of pigmented lesions. The study will involve approximately 600 patients in New York and California. The instrument is a noninvasive skin imaging tool with cellular resolution that may in the future eliminate the need for skin biopsy.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: April 2007
    Biophotonicsbiopsyconfocal microscopy technologyMicroscopyNews & FeaturesThe National Cancer Institute

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.